Pelthos Therapeutics Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Pelthos Therapeutics Ord Shs had 31.98M in cash and cash equivalents.

Pelthos Therapeutics Ord Shs reported 91.52M in total liabilities as of the latest reported quarter, including 25.99M in current liabilities and 65.52M in non-current liabilities.

As of the latest reported quarter, Pelthos Therapeutics Ord Shs's total assets were 130.40M, consisting of 53.41M in current assets and 76.99M in non-current assets.

Pelthos Therapeutics Ord Shs reported 38.88M in total shareholders' equity as of the latest reported quarter.